Saturday, 22/7/2017 | 8:43 UTC+0
Myanmar News Wire

RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

  • The second independent Data and Safety Monitoring Board (DSMB) meeting of the RHB-104 Phase III study for Crohn’s disease (MAP US study) is planned to be held in late July 2017 and will assess the safety and efficacy of RHB-104
About

About Us

The Myanmar News Wire has the long history of publishing news of all kinds to its regular readers. The website covers both domestic and international news, which is related to the Myanmar and its people. Our website is known for its unbiased reporting and that landmark, we have achieved through supporting the sense of following the basic norms of the journalism in the news industry.

Monthly Archives